Role of Dual Antiplatelet Therapy in Symptomatic Patients with Established Vascular Disease: Putting the CHARISMA Trial into Therapeutic PerspectiveBODEN, William E; FLATHER, Marcus D; BHATT, Deepak L et al.Cardiovascular drugs and therapy. 2010, Vol 24, Num 3, pp 207-216, issn 0920-3206, 10 p.Article

Ninth international symposium on long-term clinical trials, London, 19-20 June 2000KNATTERUD, Genell L; FLATHER, Marcus; TERRIN, Michael et al.Statistics in medicine. 2002, Vol 21, Num 19, issn 0277-6715, 217 p.Conference Proceedings

Recent developments in atrial fibrillationIQBAL, M. Bilal; TANEJA, Anil K; LIP, Gregory Y. H et al.BMJ. British medical journal (International ed.). 2005, Vol 330, Num 7485, pp 238-243, issn 0959-8146, 6 p.Article

Influence of valve prosthesis type on the recovery of ventricular dysfunction and subendocardial ischaemia following valve replacement for aortic stenosisCOLLINSON, Julian; FLATHER, Marcus; COATS, Andrew J. S et al.International journal of cardiology. 2004, Vol 97, Num 3, pp 535-541, issn 0167-5273, 7 p.Article

Ethical issues in clinical trials in developing countriesBRODY, Baruch A.Statistics in medicine. 2002, Vol 21, Num 19, pp 2853-2858, issn 0277-6715, 6 p.Conference Paper

Clinical research and trials in developing countriesYUSUF, Salim.Statistics in medicine. 2002, Vol 21, Num 19, pp 2859-2867, issn 0277-6715, 9 p.Conference Paper

On changing a long-term clinical trial midstreamWITTES, Janet.Statistics in medicine. 2002, Vol 21, Num 19, pp 2789-2795, issn 0277-6715, 7 p.Conference Paper

Bayesian subset analysis: application to studying treatment-by-gender interactionsSIMON, Richard.Statistics in medicine. 2002, Vol 21, Num 19, pp 2909-2916, issn 0277-6715, 8 p.Conference Paper

Regulatory perspectives on data monitoringO'NEILL, Robert T.Statistics in medicine. 2002, Vol 21, Num 19, pp 2831-2842, issn 0277-6715, 12 p.Conference Paper

The European regulatory experienceLEWIS, John A.Statistics in medicine. 2002, Vol 21, Num 19, pp 2931-2938, issn 0277-6715, 8 p.Conference Paper

Policy developments in regulatory approvalTEMPLE, Robert.Statistics in medicine. 2002, Vol 21, Num 19, pp 2939-2948, issn 0277-6715, 10 p.Conference Paper

Industry perspectives on ICH guidelinesROCKHOLD, Frank W.Statistics in medicine. 2002, Vol 21, Num 19, pp 2949-2957, issn 0277-6715, 9 p.Conference Paper

Role of the Data and Safety Monitoring Committee (DSMC)WILHELMSEN, Lars.Statistics in medicine. 2002, Vol 21, Num 19, pp 2823-2829, issn 0277-6715, 7 p.Conference Paper

Rates and causes of death from non-ST elevation acute coronary syndromes: Ten year follow-up of the PRAIS-UK registryERDEM, Guliz; BAKHAI, Ameet; TANEJA, Anil K et al.International journal of cardiology. 2013, Vol 168, Num 1, pp 490-494, issn 0167-5273, 5 p.Article

The CAPRIE-like subgroups of CHARISMA : A CAPRIEciously biased analysis of an unCHARISMAtic truth. Authors' replyGEBEL, James M; BHATT, Deepak L; FLATHER, Marcus D et al.Journal of the American College of Cardiology. 2007, Vol 50, Num 17, pp 1704-1705, issn 0735-1097, 2 p.Article

Clinical trials in the new millenniumDEMETS, David L.Statistics in medicine. 2002, Vol 21, Num 19, pp 2779-2787, issn 0277-6715, 9 p.Conference Paper

Advanced issues in the design and conduct of randomized clinical trials: the bigger the better?WARLOW, Charles.Statistics in medicine. 2002, Vol 21, Num 19, pp 2797-2805, issn 0277-6715, 9 p.Conference Paper

Issues in the meta-analysis of cluster randomized trialsDONNER, Allan; KLAR, Neil.Statistics in medicine. 2002, Vol 21, Num 19, pp 2971-2980, issn 0277-6715, 10 p.Conference Paper

Publishing research from developing countriesSMITH, Richard.Statistics in medicine. 2002, Vol 21, Num 19, pp 2869-2877, issn 0277-6715, 9 p.Conference Paper

The role of covariates in estimating treatment effects and risk in long-term clinical trialsFORD, Ian; NORRIE, John.Statistics in medicine. 2002, Vol 21, Num 19, pp 2899-2908, issn 0277-6715, 10 p.Conference Paper

The in-vitro effects of E5555, a protease-activated receptor (PAR)- I antagonist, on platelet biomarkers in healthy volunteers and patients with coronary artery diseaseSEREBRUANY, Victor L; KOGUSHI, Motoji; DASTROS-PITEI, Daniela et al.Thrombosis and haemostasis. 2009, Vol 102, Num 1, pp 111-119, issn 0340-6245, 9 p.Article

Evaluating the costs and effectiveness of cardiovascular therapies: who cares about economic analyses?CALIFF, Robert M.Statistics in medicine. 2002, Vol 21, Num 19, pp 2889-2897, issn 0277-6715, 9 p.Conference Paper

Combined endpoints: can we use them?LUBSEN, Jacobus; KIRWAN, Bridget-Anne.Statistics in medicine. 2002, Vol 21, Num 19, pp 2959-2970, issn 0277-6715, 12 p.Conference Paper

Size isn't everythingHAMPTON, J. R.Statistics in medicine. 2002, Vol 21, Num 19, pp 2807-2814, issn 0277-6715, 8 p.Conference Paper

The Cochrane Collaboration: how is it progressing?LAUPACIS, Andreas.Statistics in medicine. 2002, Vol 21, Num 19, pp 2815-2822, issn 0277-6715, 8 p.Conference Paper